PHSYX
Price
$71.54
Change
+$0.26 (+0.36%)
Updated
Dec 24 closing price
Net Assets
1.56B
VHCIX
Price
$145.26
Change
+$0.68 (+0.47%)
Updated
Dec 24 closing price
Net Assets
20.36B
Interact to see
Advertisement

PHSYX vs VHCIX

Header iconPHSYX vs VHCIX Comparison
Open Charts PHSYX vs VHCIXBanner chart's image
Putnam Global Health Care Y
Price$71.54
Change+$0.26 (+0.36%)
VolumeN/A
Net Assets1.56B
Vanguard Health Care Index Admiral
Price$145.26
Change+$0.68 (+0.47%)
VolumeN/A
Net Assets20.36B
PHSYX vs VHCIX Comparison Chart in %
View a ticker or compare two or three
VS
PHSYX vs. VHCIX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHSYX is a Buy and VHCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VHCIX has more cash in the bank: 20.4B vs. PHSYX (1.56B). VHCIX pays higher dividends than PHSYX: VHCIX (1.32) vs PHSYX (0.49). PHSYX was incepted earlier than VHCIX: PHSYX (26 years) vs VHCIX (22 years). PHSYX (0.80) is less costly to investors than VHCIX (0.09). PHSYX is a more actively managed with annual turnover of: 36.00 vs. VHCIX (4.00). PHSYX has a lower initial minimum investment than VHCIX: PHSYX (0) vs VHCIX (100000). VHCIX (13.11) and PHSYX (12.87) have marching annual gain over last year. VHCIX return over 5 years is better than : 31.09 vs. PHSYX (14.50).
PHSYXVHCIXPHSYX / VHCIX
Total Expense Ratio0.800.09889%
Annual Report Gross Expense Ratio0.800.09889%
Fund Existence26 years22 years-
Gain YTD14.31814.67498%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.56B20.4B8%
Annual Yield % from dividends0.491.3237%
Returns for 1 year12.8713.1198%
Returns for 3 years16.3617.1795%
Returns for 5 years14.5031.0947%
Returns for 10 years11.38117.6110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.09N/A
+1.12%
Oncotelic Therapeutics, Inc.
RSSFF0.04N/A
N/A
Affinor Growers, Inc.
SEBYY5.47N/A
N/A
SEB S.A.
SBHMY18.22N/A
N/A
Sino Biopharmaceutical Ltd.
FPLPF1.51N/A
N/A
VANQUIS BKG GROUP PLC